Literature DB >> 9010234

Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo.

Q Lu1, M P Kamps.   

Abstract

Hox proteins control genetic programs that orchestrate development, and a large subset of Hox proteins can bind DNA elements as heterodimers with the Pbx family of homeodomain proteins. A transcriptionally activated version of Pbx1, E2a-Pbx1, is an oncoprotein in human pre-B cell leukemia that strongly suppresses differentiation and retains its ability to heterodimerize with Hox proteins. Because monomeric Hox proteins bind very similar DNA motifs, it is unclear how they activate diverse developmental programs. Here we demonstrate that heterodimers containing different Hox proteins and a common Pbx1 or E2a-Pbx1 partner bind different DNA motifs. Structural models suggest that the specificity of the Hox protein is altered by a conformation change involving residues in the N-terminal arm of the Hox homeodomain. Mutational analysis also supported the hypothesis that unique sequences in the N-terminal arm of the Hox homeodomain are at least partially responsible for mediating this specificity. In vivo, Hox proteins directed E2a-Pbx1-mediated transactivation with moderate specificity to cognate Hox-Pbx motifs. Thus, the development specificity of individual Hox proteins may be mediated, in part, by differential targeting of cellular genes by Pbx1-Hox complexes. Likewise, through its function as a common heterodimer partner, oncoprotein E2a-Pbx1 may be able to interfere with multiple programs of development that are induced by the sequential or simultaneous expression of Hox proteins during hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9010234     DOI: 10.1038/sj.onc.1200799

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins.

Authors:  C P Chang; Y Jacobs; T Nakamura; N A Jenkins; N G Copeland; M L Cleary
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 2.  The Hox genes and their roles in oncogenesis.

Authors:  Nilay Shah; Saraswati Sukumar
Journal:  Nat Rev Cancer       Date:  2010-04-01       Impact factor: 60.716

3.  E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.

Authors:  Wen-Chieh Pi; Jun Wang; Miho Shimada; Jia-Wei Lin; Huimin Geng; Yu-Ling Lee; Rui Lu; Dongxu Li; Gang Greg Wang; Robert G Roeder; Wei-Yi Chen
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

Review 4.  Molecular genetics of B-precursor acute lymphoblastic leukemia.

Authors:  Charles G Mullighan
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

5.  Cofactor binding evokes latent differences in DNA binding specificity between Hox proteins.

Authors:  Matthew Slattery; Todd Riley; Peng Liu; Namiko Abe; Pilar Gomez-Alcala; Iris Dror; Tianyin Zhou; Remo Rohs; Barry Honig; Harmen J Bussemaker; Richard S Mann
Journal:  Cell       Date:  2011-12-09       Impact factor: 41.582

6.  Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1.

Authors:  P S Knoepfler; K R Calvo; H Chen; S E Antonarakis; M P Kamps
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 7.  Hox genes and their candidate downstream targets in the developing central nervous system.

Authors:  Z N Akin; A J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

8.  CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.

Authors:  L H Kasper; P K Brindle; C A Schnabel; C E Pritchard; M L Cleary; J M van Deursen
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

Review 9.  Hox regulation of transcription: more complex(es).

Authors:  Franck Ladam; Charles G Sagerström
Journal:  Dev Dyn       Date:  2013-07-22       Impact factor: 3.780

10.  ADP ribosylation by PARP-1 suppresses HOXB7 transcriptional activity.

Authors:  Xinyan Wu; Stephan Ellmann; Ethel Rubin; Minchan Gil; Kideok Jin; Liangfeng Han; Hexin Chen; Erika M Kwon; Jianhui Guo; Hyo Chol Ha; Saraswati Sukumar
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.